Clinical trials
Active, not recruiting Nervous System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Taysha Gene Therapies, Inc. | 2 |
| 4D Molecular Therapeutics | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Axogen Corporation | 1 |
| Beacon Therapeutics | 1 |
| Burke Medical Research Institute | 1 |
| Capricor Inc. | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| EIP Pharma Inc | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 24 |
| Central Nervous System Diseases | 7 |
| Brain Diseases | 6 |
| Genetic Diseases, Inborn | 6 |
| Genetic Diseases, X-Linked | 5 |
| Neurologic Manifestations | 5 |
| Cardiovascular Diseases | 4 |
| Muscular Dystrophies | 4 |
| Neurodegenerative Diseases | 4 |
| Neurodevelopmental Disorders | 4 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.